Progress in research of L1CAM in early endometrial carcinoma

doi:10.3877/cma.j.issn.1674-0785.2017.13.009

Abstract

Abstract:

L1 cell adhesion molecule (L1CAM) is a kind of cell adhesion molecule consisting of a series of protein domains, playing an important role in the regulation of nerve cell movement and growth. Studies show that L1CAM expressed in tumor cells can promote cell proliferation, migration, invasion, and metastasis, which affects the prognosis of patients with tumors. Recently, some researchers have detected L1CAM expression in early endometrial carcinoma tissue by immunohistochemistry and analyzed the adverse influence of L1CAM on the prognosis of patients with endometrial carcinoma. This article discusses the mechanism of L1CAM in tumor cell metastasis, especially the relationship between L1CAM and epithelial-mesenchymal transition (EMT), and its influence on the prognosis of patients with endometrial cancer, in order to further explore the adverse prognostic factors of endometrial carcinoma and provide evidence for more precise treatment of this malignancy.

Key words: Endometrial cancer, L1CAM, EMT, Lymphatic metastasis, Prognosis

Qingmin Wang, Xianghua Yin. Progress in research of L1CAM in early endometrial carcinoma[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(13): 2002-2005.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2017.13.009

https://zhlcyszz.cma-cmc.com.cn/EN/Y2017/V11/I13/2002

References 25

[1]	谢幸, 苟文丽. 妇产科学[M]. 北京: 人民卫生出版社, 2016.
[2]	Kiefel H, Bondong S, Hazin J, et al. L1CAM A major driver for tumor cell invasion and motility [J]. Cell Adh Migr, 2012, 6(4): 374-384.
[3]	Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers [J]. Cell Biol, 2015, 168(4): 633-642.
[4]	Huszar M, Pfeifer M, Schirmer U, et al. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas [J]. J Pathol, 2010, 220(5): 551-561.
[5]	Altevogt P, Doberstein K, Fogel M, et al. L1CAM in human cancer [J]. Int J Cancer, 2016, 138(7): 1565-1576.
[6]	Zecchini S, Bianchi M, Colombo N, et al. The differential role of l1 in ovarian carcinoma and normal ovarian surface epithelium [J]. Cancer Res, 2008, 68(4): 1110-1118
[7]	Stoeck A, Keller S, Riedle S, et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44 [J]. Biochem J, 2006, 393(3): 609-618.
[8]	Colas E, Pedrola N, Devis L, et al. The EMT signaling pathways in endometrial carcinoma [J]. Clin Transl Oncol, 2012, 14(10): 715-720.
[9]	Shtutman M, Levina E, Ohouo P, et al. Celladhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells [J]. Cancer Res, 2006, 66(23): 11370-11380.
[10]	Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers [J]. J Cell Biol, 2005, 168(4): 633-642.
[11]	Silletti S, Yebra M, Perez B, et al. Extracellular signal-regulated kinase(ERK)-dependent gene expression contributes to L1 Cell adhesion molecule-dependent motility and invasion [J]. J Biol Chem, 2004, 24(28): 28880-28888.
[12]	卞奕丁，万小平. Wnt信号通路与子宫内膜癌研究进展 [J]. 现代妇产科进展, 2015, 24(11): 867-869.
[13]	Schaefer AW, Kamiguchi H, Wong EV, et al. Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization [J]. J Biol Chem, 1999, 274(53): 37965-37973.
[14]	Batlle E, Bacani J, Begthel H, et al. Eph B/Ephrin B receptors and Wnt signaling incolorectal cancer [J]. Cancer Res, 2006, (66): 2-5.
[15]	Connacci-Sorell M, Zhurinski J, Ben-Ze′ev A. The cadherin-catenin adhesion system in signaling and cancer [J]. J Clin Invest, 2002, 109(8): 987-991.
[16]	Meier F, Busch S, Gast D, et al. The adhesion molecule L1(CD171) promotes melanoma progression [J]. Int J Cancer, 2006, 119(3): 549-555.
[17]	Gutwein P, Stoeck A, Riedle S, et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells [J]. Clin. Cancer Res, 2005, 11(7): 2492-2501.
[18]	Fogel M, Gutwein P, Mechtersheimer S, et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas [J].. Lancet, 2003, 362(9387): 869-875.
[19]	Dellinger TH, Smith DD, Ouyang C, et al. L1CAM is an independent predictor of poor survival in endometrialcancer - An analysis of The Cancer Genome Atlas(TCGA) [J]. Gynecologic Oncol, 2016, 141(2): 336-340.
[20]	Zeimet AG, Reimer D, Huszar M, et al. L1CAM in early-Stage type I endometrial cancer: results of a large Multicenter evaluation [J]. J Natl Cancer Inst, 2013, 105(15): 1142-1150.
[21]	Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC Cohorts [J]. Clin Cancer Res, 2016, 22(16): 4215-4224.
[22]	Suh DH, Kim MA, Kim HS, et al. L1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control study [J]. Cancer Prev, 2014, 19(3): 231-239.
[23]	Geels YP, Pijnenborg JM, Gorden BB, et al. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma [J]. Pathol, Oncol Res, 2016, 22(4): 863-868.
[24]	Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition incancer: parallels between normal development and tumor progression [J]. Mammary Gland Biol Neoplasia, 2010, 15(2): 117-134.
[25]	Abdel Azim S, Sprung S, Mutz-Dehbalaie I, et al. L1CAM and HER2 expression in early endometrioid uterine cancer [J]. Int J Gynecol Pathol, 2017, 36(4): 356-363.

Please choose a citation manager

Content to export